David L. Willins

1.6k total citations
14 papers, 1.3k citations indexed

About

David L. Willins is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, David L. Willins has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in David L. Willins's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Receptor Mechanisms and Signaling (8 papers). David L. Willins is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Receptor Mechanisms and Signaling (8 papers). David L. Willins collaborates with scholars based in United States and Denmark. David L. Willins's co-authors include Bryan L. Roth, Herbert Y. Meltzer, Ariel Y. Deutch, Wesley K. Kroeze, Norman J. Uretsky, Lane J. Wallace, Susan A. Berry, Kurt Kristiansen, Elaine Sanders‐Bush and J.R. Backstrom and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

David L. Willins

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Willins United States 13 1.1k 740 209 140 104 14 1.3k
Sylvie Chaboz Switzerland 9 1.1k 1.0× 692 0.9× 418 2.0× 104 0.7× 81 0.8× 9 1.5k
B M Baron United States 15 767 0.7× 575 0.8× 66 0.3× 96 0.7× 127 1.2× 21 1.1k
Brenda Trail United Kingdom 11 716 0.7× 432 0.6× 86 0.4× 123 0.9× 88 0.8× 15 975
Pokman Chan United States 5 1000 0.9× 618 0.8× 542 2.6× 93 0.7× 63 0.6× 7 1.3k
Vicki L. Coffin United States 21 998 0.9× 676 0.9× 61 0.3× 211 1.5× 211 2.0× 41 1.4k
Jesse Brodkin United States 18 1.4k 1.3× 1.0k 1.4× 135 0.6× 232 1.7× 46 0.4× 20 1.9k
Vicky Holland United Kingdom 11 584 0.6× 369 0.5× 70 0.3× 156 1.1× 99 1.0× 13 988
C J Schmidt United States 17 1.4k 1.3× 782 1.1× 399 1.9× 145 1.0× 195 1.9× 21 1.9k
Mike Bickerdike United Kingdom 10 492 0.5× 283 0.4× 119 0.6× 71 0.5× 72 0.7× 15 741
Rosalind L. Ang United States 7 972 0.9× 677 0.9× 540 2.6× 90 0.6× 64 0.6× 8 1.4k

Countries citing papers authored by David L. Willins

Since Specialization
Citations

This map shows the geographic impact of David L. Willins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Willins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Willins more than expected).

Fields of papers citing papers by David L. Willins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Willins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Willins. The network helps show where David L. Willins may publish in the future.

Co-authorship network of co-authors of David L. Willins

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Willins. A scholar is included among the top collaborators of David L. Willins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Willins. David L. Willins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Kristiansen, Kurt, Wesley K. Kroeze, David L. Willins, et al.. (2000). A Highly Conserved Aspartic Acid (Asp-155) Anchors the Terminal Amine Moiety of Tryptamines and Is Involved in Membrane Targeting of the 5-HT2A Serotonin Receptor But Does Not Participate in Activation via a “Salt-Bridge Disruption” Mechanism. Journal of Pharmacology and Experimental Therapeutics. 293(3). 735–746. 101 indexed citations
3.
Willins, David L., Susan A. Berry, J.R. Backstrom, et al.. (1999). Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience. 91(2). 599–606. 130 indexed citations
4.
Roth, Bryan L., David L. Willins, Kurt Kristiansen, & Wesley K. Kroeze. (1999). Activation is Hallucinogenic and Antagonism is Therapeutic: Role of 5-HT2A Receptors in Atypical Antipsychotic Drug Actions. The Neuroscientist. 5(4). 254–262. 19 indexed citations
5.
Willins, David L., et al.. (1998). G protein-coupled receptor (GPCR) trafficking in the central nervous system: relevance for drugs of abuse. Drug and Alcohol Dependence. 51(1-2). 73–85. 52 indexed citations
6.
Willins, David L., Susan A. Berry, J.R. Backstrom, et al.. (1998). Serotonergic Antagonist Effects on Trafficking of Serotonin 5‐HT2A Receptors in Vitro and in Vivoa. Annals of the New York Academy of Sciences. 861(1). 121–127. 41 indexed citations
7.
Roth, Bryan L., Susan A. Berry, Wesley K. Kroeze, David L. Willins, & Kurt Kristiansen. (1998). Serotonin 5-HT2A Receptors: Molecular Biology and Mechanisms of Regulation. PubMed. 12(4). 319–338. 91 indexed citations
8.
Willins, David L. & Herbert Y. Meltzer. (1998). Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Research. 781(1-2). 291–299. 61 indexed citations
9.
Willins, David L., Ariel Y. Deutch, & Bryan L. Roth. (1997). Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 27(1). 79–82. 276 indexed citations
10.
Hill, Ronald A., Lane J. Wallace, Duane D. Miller, et al.. (1997). Structure−Activity Studies for α-Amino-3-hydroxy-5-methyl-4-isoxazolepropanoic Acid Receptors:  Acidic Hydroxyphenylalanines. Journal of Medicinal Chemistry. 40(20). 3182–3191. 5 indexed citations
11.
Willins, David L. & Herbert Y. Meltzer. (1997). Direct Injection of 5-HT2A Receptor Agonists into the Medial Prefrontal Cortex Produces a Head-Twitch Response in Rats. Journal of Pharmacology and Experimental Therapeutics. 282(2). 699–706. 210 indexed citations
12.
Willins, David L., et al.. (1993). The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801. Pharmacology Biochemistry and Behavior. 46(4). 881–887. 80 indexed citations
13.
Willins, David L., Lane J. Wallace, David D. Miller, & Norman J. Uretsky. (1992). alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1145–1151. 43 indexed citations
14.
Boldry, Robert C., David L. Willins, Lane J. Wallace, & Norman J. Uretsky. (1991). The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA. Brain Research. 559(1). 100–108. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026